If youre cutting back on meat, these legumes serve as an excellent plant-based protein option
Lilly's next-gen Triple G (GLP-1/GIP/glucagon) agonist (Phase 1b, Phase 2): started recruiting for a Phase 3 trial this year approvals are expected by 2026
35 Without this stimulus, especially during a calorie deficit potentially exacerbated by GLP-1 effects, the body may be less efficient at utilizing dietary protein for muscle maintenance, leading to greater lean mass loss
What You Should Know: Noom, a digital healthcare company, is shaking up the weight loss industry with the launch of Noom GLP-1Rx, an innovative program offers affordable, accessible, and sustainable weight loss by combining compounded GLP-1 injections with Nooms proven behavioral change program
Tirzepatide can help clarify which path makes the most sense for your goals
10 GLP-1 receptor agonists (GLP-1RAs), or incretin mimetics, are currently among the most promising drugs for adjusting metabolic function, playing significant roles in the management of T2DM, and some have been approved for obesity management